These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 33572168)
1. Lyophilized Drug-Loaded Solid Lipid Nanoparticles Formulated with Beeswax and Theobroma Oil. Amekyeh H; Billa N Molecules; 2021 Feb; 26(4):. PubMed ID: 33572168 [TBL] [Abstract][Full Text] [Related]
2. Correlating gastric emptying of amphotericin B and paracetamol solid lipid nanoparticles with changes in particle surface chemistry. Amekyeh H; Billa N; Roberts C Int J Pharm; 2017 Jan; 517(1-2):42-49. PubMed ID: 27923696 [TBL] [Abstract][Full Text] [Related]
3. A gastrointestinal transit study on amphotericin B-loaded solid lipid nanoparticles in rats. Amekyeh H; Billa N; Yuen KH; Chin SL AAPS PharmSciTech; 2015 Aug; 16(4):871-7. PubMed ID: 25588365 [TBL] [Abstract][Full Text] [Related]
4. Further characterization of theobroma oil-beeswax admixtures as lipid matrices for improved drug delivery systems. Attama AA; Schicke BC; Müller-Goymann CC Eur J Pharm Biopharm; 2006 Nov; 64(3):294-306. PubMed ID: 16949805 [TBL] [Abstract][Full Text] [Related]
5. Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles. Howard MD; Lu X; Jay M; Dziubla TD Drug Dev Ind Pharm; 2012 Oct; 38(10):1270-9. PubMed ID: 22235767 [TBL] [Abstract][Full Text] [Related]
6. Solvent injection-lyophilization of tert-butyl alcohol/water cosolvent systems for the preparation of drug-loaded solid lipid nanoparticles. Wang T; Wang N; Zhang Y; Shen W; Gao X; Li T Colloids Surf B Biointerfaces; 2010 Aug; 79(1):254-61. PubMed ID: 20447810 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax. Kheradmandnia S; Vasheghani-Farahani E; Nosrati M; Atyabi F Nanomedicine; 2010 Dec; 6(6):753-9. PubMed ID: 20599527 [TBL] [Abstract][Full Text] [Related]
8. Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations. Jansook P; Fülöp Z; Ritthidej GC Drug Dev Ind Pharm; 2019 Apr; 45(4):560-567. PubMed ID: 30632399 [TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil. Shi F; Zhao JH; Liu Y; Wang Z; Zhang YT; Feng NP Int J Nanomedicine; 2012; 7():2033-43. PubMed ID: 22619540 [TBL] [Abstract][Full Text] [Related]
10. Topical Amphotericin B solid lipid nanoparticles: Design and development. Butani D; Yewale C; Misra A Colloids Surf B Biointerfaces; 2016 Mar; 139():17-24. PubMed ID: 26700229 [TBL] [Abstract][Full Text] [Related]
11. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. Vivek K; Reddy H; Murthy RS AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544 [TBL] [Abstract][Full Text] [Related]
12. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related]
13. Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations. Jansook P; Pichayakorn W; Ritthidej GC Drug Dev Ind Pharm; 2018 Oct; 44(10):1693-1700. PubMed ID: 29936874 [TBL] [Abstract][Full Text] [Related]
14. Characterization and stability of nanostructured lipid carriers as drug delivery system. Abbasalipourkabir R; Salehzadeh A; Abdullah R Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of miscibility and polymorphism of synthetic and natural lipids for nanostructured lipid carrier (NLC) formulations by Raman mapping and multivariate curve resolution (MCR). Mitsutake H; Ribeiro LNM; Rodrigues da Silva GH; Castro SR; de Paula E; Poppi RJ; Breitkreitz MC Eur J Pharm Sci; 2019 Jul; 135():51-59. PubMed ID: 31071439 [TBL] [Abstract][Full Text] [Related]
16. Effect of Food Status on the Gastrointestinal Transit of Amphotericin B-Containing Solid Lipid Nanoparticles in Rats. Amekyeh H; Billa N; Yuen KH; Lim SC AAPS PharmSciTech; 2016 Oct; 17(5):1060-6. PubMed ID: 26511938 [TBL] [Abstract][Full Text] [Related]
17. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs. Shah RM; Eldridge DS; Palombo EA; Harding IH Int J Pharm; 2016 Dec; 515(1-2):543-554. PubMed ID: 27789371 [TBL] [Abstract][Full Text] [Related]
18. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995 [TBL] [Abstract][Full Text] [Related]
19. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration. Song A; Zhang X; Li Y; Mao X; Han F Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734 [TBL] [Abstract][Full Text] [Related]
20. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Liu CH; Wu CT; Fang JY Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]